Cubist Systematic Strategies, LLC Sangamo Therapeutics, Inc Transaction History

Cubist Systematic Strategies, LLC

$15.8 Billion
Q3 2024

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$0.36 - $0.65 $66,892 - $120,778	185,813 New	185,813 $66,000
Q3 2023 Nov 14, 2023	SELL	$0.58 - $1.47 $108,890 - $275,982	-187,743 Reduced 98.86%	2,173 $1,000
Q2 2023 Aug 14, 2023	BUY	$1.11 - $1.74 $173,206 - $271,513	156,042 Added 460.65%	189,916 $246,000
Q1 2023 May 15, 2023	BUY	$1.66 - $3.67 $56,230 - $124,317	33,874 New	33,874 $59,000
Q3 2022 Nov 14, 2022	SELL	$4.27 - $6.39 $891,768 - $1.33 Million	-208,845 Reduced 48.88%	218,429 $1.07 Million
Q2 2022 Aug 15, 2022	BUY	$3.28 - $6.21 $1.21 Million - $2.29 Million	368,151 Added 622.69%	427,274 $1.77 Million
Q1 2022 May 16, 2022	SELL	$5.23 - $7.82 $562,878 - $841,627	-107,625 Reduced 64.54%	59,123 $344,000
Q4 2021 Feb 14, 2022	BUY	$7.29 - $10.97 $739,235 - $1.11 Million	101,404 Added 155.18%	166,748 $1.25 Million
Q3 2021 Nov 15, 2021	SELL	$9.01 - $12.01 $136,141 - $181,471	-15,110 Reduced 18.78%	65,344 $589,000
Q2 2021 Aug 16, 2021	BUY	$10.17 - $12.64 $558,322 - $693,923	54,899 Added 214.83%	80,454 $963,000
Q1 2021 May 17, 2021	SELL	$10.88 - $17.05 $1.24 Million - $1.94 Million	-113,543 Reduced 81.63%	25,555 $320,000
Q4 2020 Feb 16, 2021	BUY	$9.23 - $18.18 $454,965 - $896,128	49,292 Added 54.89%	139,098 $2.17 Million
Q3 2020 Nov 16, 2020	SELL	$9.38 - $12.48 $325,673 - $433,305	-34,720 Reduced 27.88%	89,806 $849,000
Q2 2020 Aug 14, 2020	BUY	$6.21 - $11.83 $580,957 - $1.11 Million	93,552 Added 302.03%	124,526 $1.12 Million
Q1 2020 May 15, 2020	SELL	$5.05 - $8.85 $340,501 - $596,720	-67,426 Reduced 68.52%	30,974 $197,000
Q4 2019 Feb 14, 2020	BUY	$8.03 - $11.7 $790,151 - $1.15 Million	98,400 New	98,400 $824,000
Q3 2019 Nov 14, 2019	SELL	$9.05 - $12.22 $619,725 - $836,801	-68,478 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$8.75 - $13.03 $133,043 - $198,121	15,205 Added 28.54%	68,478 $738,000
Q1 2019 May 15, 2019	BUY	$7.72 - $12.81 $283,594 - $470,575	36,735 Added 222.12%	53,273 $508,000
Q4 2018 Feb 14, 2019	BUY	$9.51 - $16.6 $157,276 - $274,530	16,538 New	16,538 $190,000
Q2 2018 Aug 14, 2018	SELL	$13.9 - $19.8 $904,709 - $1.29 Million	-65,087 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$16.7 - $26.35 $716,713 - $1.13 Million	42,917 Added 193.58%	65,087 $1.24 Million
Q4 2017 Feb 14, 2018	BUY	$11.6 - $17.35 $25,844 - $38,655	2,228 Added 11.17%	22,170 $364,000
Q3 2017 Nov 14, 2017	BUY	$8.4 - $15.0 $167,512 - $299,130	19,942	19,942 $299,000

Others Institutions Holding SGMO

# of Institutions

114

Shares Held

56.3M

Call Options Held

576K

Put Options Held

1.17M

Wasatch Advisors Inc Salt Lake City, UT

19.4M
Shares

$39.9 Million
0.08% of portfolio
Vanguard Group Inc Valley Forge, PA

9.6M
Shares

$19.7 Million
0.0% of portfolio
Jim Simons Renaissance Technologies LLC | New York, Ny

4.85M
Shares

$9.95 Million
0.01% of portfolio
Black Rock Inc. New York, NY

4.7M
Shares

$9.64 Million
0.0% of portfolio
Marshall Wace, LLP London, X0

2.35M
Shares

$4.83 Million
0.0% of portfolio

View Full List

About SANGAMO THERAPEUTICS, INC

Ticker SGMO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 156,552,992
Market Cap $321M
Description
Sangamo Therapeutics, Inc., a clinical-stage biotechnology company, focuses on translating science into genomic medicines that transform patients' lives using platform technologies in gene therapy, cell therapy, genome editing, and genome regulation. The company offers zinc finger protein (ZFP), a technology platform for making zinc finger nucle...

More about SGMO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.

Account